The 13 analysts offering 12-month price forecasts for Encompass Health Corp have a median target of 95.00, with a high estimate of 106.00 and a low estimate of 70.00. The median estimate represents a +10.83% increase from the last price of 85.72.
The current consensus among 14 polled investment analysts is to Buy stock in Encompass Health Corp. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.85
Reporting Date Jan 27
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.